Estrogen supplements in menopause.
The number of women aged 65 and older is expected to double by the year 2000, increasing the need for effective management of symptoms related to menopause. Contemporary management of menopause addresses the continuum of events associated with the effects of estrogen deprivation on quality and duration of life, including neuroendocrine changes, urogenital atrophy, sexual dysfunction, skin and hair changes, osteoporosis, and cardiovascular disease. The risks and benefits of management strategies, including hormone replacement therapy, must be weighted carefully by both physician and patient. The use of estrogens and progestins, alterative compounds, dosages, routes of administration, and their advantages and disadvantages must be analyzed.
Booher
D L
DL
Department of Gynecology, Cleveland Clinic Foundation, Ohio 44195.
D000368:Aged; D002318:Cardiovascular Diseases / Q000209:etiology / Q000401:mortality; D004334:Drug Administration Schedule; D015914:Estrogen Replacement Therapy / Q000379:methods; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008593:Menopause; D010024:Osteoporosis / Q000209:etiology / Q000628:therapy; D011374:Progesterone / Q000008:administration & dosage / Q000627:therapeutic use; D011788:Quality of Life; D014481:United States
D004967:Estrogens; D011374:Progesterone